Magnetic Lateral Flow Immunoassay for Small Extracellular Vesicles Quantification: Application to Colorectal Cancer Biomarker Detection

Colorectal cancer (CRC) is the third leading cause of cancer death and the fourth most common cancer in the world. Colonoscopy is the most sensitive test used for detection of CRC; however, their procedure is invasive and expensive for population mass screening. Currently, the fecal occult blood test has been widely used as a screening tool for CRC but displays low specificity. The lack of rapid and simple methods for mass screening makes the early diagnosis and therapy monitoring difficult. Extracellular vesicles (EVs) have emerged as a novel source of biomarkers due to their contents in proteins and miRNAs. Their detection would not require invasive techniques and could be considered as a liquid biopsy. Specifically, it has been demonstrated that the amount of CD147 expressed in circulating EVs is significant higher for CRC cell lines than for normal colon fibroblast cell lines. Moreover, CD147-containing EVs have been used as a biomarker to monitor response to therapy in patients with CRC. Therefore, this antigen could be used as a non-invasive biomarker for the detection and monitoring of CRC in combination with a Point-of-Care platform as, for example, Lateral Flow Immunoassays (LFIAs). Here, we propose the development of a quantitative lateral flow immunoassay test based on the use of magnetic nanoparticles as labels coupled to inductive sensor for the non-invasive detection of CRC by CD147-positive EVs. The results obtained for quantification of CD147 antigen embedded in EVs isolated from plasma sample have demonstrated that this device could be used as a Point-of-Care tool for CRC screening or therapy monitoring thanks to its rapid response and easy operation.

[1]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[2]  M. Yáñez-Mó,et al.  Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids , 2016, Journal of extracellular vesicles.

[3]  R. Simpson,et al.  Exosomes and their roles in immune regulation and cancer. , 2015, Seminars in cell & developmental biology.

[4]  Muhammad Sajid,et al.  Designs, formats and applications of lateral flow assay: A literature review , 2015 .

[5]  D. Lago-Cachón,et al.  Eddy-current sensing of superparamagnetic nanoparticles with spiral-like copper circuits , 2014 .

[6]  E. Cisneros,et al.  Analysis of exosome release and its prognostic value in human colorectal cancer , 2012, Genes, chromosomes & cancer.

[7]  B. Toole,et al.  How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity , 2015, Bioscience reports.

[8]  P. Tekkis,et al.  Systematic review of blood diagnostic markers in colorectal cancer , 2018, Techniques in Coloproctology.

[9]  E. Bahadır,et al.  Lateral flow assays: Principles, designs and labels , 2016 .

[10]  M. Yáñez-Mó,et al.  Point-of-care detection of extracellular vesicles: Sensitivity optimization and multiple-target detection. , 2017, Biosensors & bioelectronics.

[11]  S. M. Taghdisi,et al.  Exosomes, new biomarkers in early cancer detection. , 2019, Analytical biochemistry.

[12]  L. Bubacco,et al.  Exosomes-associated neurodegeneration and progression of Parkinson's disease. , 2012, American journal of neurodegenerative disease.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  Xiaolin Huang,et al.  Magnetic Quantum Dot Nanobead-Based Fluorescent Immunochromatographic Assay for the Highly Sensitive Detection of Aflatoxin B1 in Dark Soy Sauce. , 2019, Analytical chemistry.

[15]  J. Castro-Marrero,et al.  Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study , 2018, Journal of extracellular vesicles.

[16]  C. Navarro,et al.  Cancer incidence in Spain, 2015 , 2017, Clinical and Translational Oncology.

[17]  Huajian Gu,et al.  CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis , 2016, Scientific Reports.

[18]  M. Yáñez-Mó,et al.  Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma , 2018, Journal of Nanobiotechnology.

[19]  M. Belting,et al.  Role of exosomes and microvesicles in hypoxia‐associated tumour development and cardiovascular disease , 2015, Journal of internal medicine.

[20]  C. Lebbé,et al.  CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker , 2019, Cancers.

[21]  O. Marinică,et al.  Sterically stabilized water based magnetic fluids : Synthesis, structure and properties , 2007 .

[22]  J. Orozco,et al.  Electrochemical Biosensors for Determination of Colorectal Tumor Biomarkers , 2020, Micromachines.

[23]  Anatoly V Zherdev,et al.  Double-enhanced lateral flow immunoassay for potato virus X based on a combination of magnetic and gold nanoparticles. , 2018, Analytica chimica acta.

[24]  Laura M Lechuga,et al.  Label-free nanoplasmonic sensing of tumor-associate autoantibodies for early diagnosis of colorectal cancer. , 2016, Analytica chimica acta.

[25]  A. Navarro,et al.  Characterization of Plasma-Derived Extracellular Vesicles Isolated by Different Methods: A Comparison Study , 2019, Bioengineering.

[26]  J. Rak,et al.  Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer , 2013, Front. Pharmacol..

[27]  L. Vékás,et al.  Magnetic immunochromatographic test for histamine detection in wine , 2019, Analytical and Bioanalytical Chemistry.

[28]  G. Jenster,et al.  Immuno‐based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer , 2015, International journal of cancer.

[29]  B. D. Malhotra,et al.  Protein functionalised self assembled monolayer based biosensor for colon cancer detection. , 2019, Talanta.

[30]  J. C. Martínez-García,et al.  Magnetic Lateral Flow Immunoassays , 2020, Diagnostics.

[31]  Yusuke Yoshioka,et al.  Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen , 2014, Nature Communications.

[32]  M. P. Puerto Morales,et al.  Improved magnetic lateral flow assays with optimized nanotags for point-of-use inductive biosensing. , 2020, The Analyst.

[33]  M. Büchler,et al.  Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity , 2015, International journal of cancer.

[34]  Zhibin Li,et al.  Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry. , 2018, ACS nano.

[35]  Ebrahim Ghafar-Zadeh,et al.  An Apta-Biosensor for Colon Cancer Diagnostics , 2015, Sensors.

[36]  R. De Maria,et al.  CD147 Promotes Cell Small Extracellular Vesicles Release during Colon Cancer Stem Cells Differentiation and Triggers Cellular Changes in Recipient Cells , 2020, Cancers.

[37]  Y. Piñeiro,et al.  Carbon-Coated Superparamagnetic Nanoflowers for Biosensors Based on Lateral Flow Immunoassays , 2020, Biosensors.

[38]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[39]  M. Rivas,et al.  Cu impedance-based detection of superparamagnetic nanoparticles , 2013, Nanotechnology.

[40]  David Lago-Cachón,et al.  Scanning Magneto-Inductive Sensor for Quantitative Assay of Prostate-Specific Antigen , 2017, IEEE Magnetics Letters.

[41]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[42]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[43]  Stefano Fais,et al.  Exosomes: the future of biomarkers in medicine. , 2013, Biomarkers in medicine.

[44]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[45]  Alexandr E Urusov,et al.  Towards Lateral Flow Quantitative Assays: Detection Approaches , 2019, Biosensors.